Non Hodgkin's lymphomas: a major breakthrough with immunotherapy

Non hodgkin's lymphomas are a group of haematological malignancies in which spectacular progress has been made over the last ten years thanks to immunotherapy. Furthermore, the new WHO classification, based upon tumour immunology, the degree of tumour differentiation and cytogenetic abnormaliti...

Full description

Saved in:
Bibliographic Details
Published inRevue médicale de Bruxelles Vol. 32; no. 2; pp. 83 - 92
Main Authors Firescu, R, Muylle, K, Roelandts, M, de Wind, A, Moerman, C, Lemort, M, Kentos, A, Meuleman, N, Bron, D
Format Journal Article
LanguageFrench
Published Belgium 01.03.2011
Subjects
Humans
Immunotherapy
Lymphoma, Non-Hodgkin - therapy
Practice Guidelines as Topic
Online AccessGet full text

Cover

More Information
Summary:Non hodgkin's lymphomas are a group of haematological malignancies in which spectacular progress has been made over the last ten years thanks to immunotherapy. Furthermore, the new WHO classification, based upon tumour immunology, the degree of tumour differentiation and cytogenetic abnormalities, has finally improved identification of each lymphoma and has enabled comparison of homogeneous populations between different clinical studies. The increase in the incidence of non hodgkin's lymphoma is related to the aging of the population and to other factors that are yet to be elucidated--a real challenge for the future. We have tried to offer an overview of the latest therapeutic advances, with a focus on (radio-) immunotherapy and haemopoietic stem cell transplantation.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0035-3639